Abdul Rafeh Awan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdul Rafeh Awan has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
Muhammad Ahmad Nadeem
8 shared publicationsAbu Baker Sheikh
6 shared publications- Muhammad Ahmad Nadeem
Department of Liver Transplant Surgery, Cleveland Clinic
6 shared publications - Amir Humza Sohail
Department of Surgery, University of New Mexico, Albuquerque, USA
5 shared publications Jibran Ikram
5 shared publicationsAmir Humza Sohail
4 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by S. Karger AG in Digestive Diseases
- p. 1-11
Association between Proton Pump Inhibitor and Clostridioides difficile Risk in ICU Patients: A Systematic Review and Meta-Analysis of Clinical Outcomes
Introduction: Clostridioides difficile infection (CDI) is a leading cause of antibiotic-associated diarrhea in critically ill patients. This meta-analysis evaluated whether proton pump inhibitor-based stress ulcer prophylaxis increases CDI risk and examined associated outcomes, including mortality, gastrointestinal bleeding, and other clinical effects in ICU patients. Methods: The study was prospectively registered on PROSPERO (CRD420251176540). Following PRISMA guidelines, PubMed, Scopus, Cochrane, and Google Scholar were searched (2007 – March 2025) for randomized controlled trials and observational studies comparing PPIs with H2 receptor antagonists (H2RAs) or placebo in ICU patients. Data were pooled using a random-effects model, and heterogeneity was assessed using the I2 statistic. Results: Eight studies (∼58,000 patients) met inclusion criteria. PPI use did not significantly increase CDI risk (OR 1.12; p = 0.49, I2 = 73%) or mortality (RR 1.01; p = 0.70) but significantly reduced gastrointestinal bleeding risk (RR 0.60; p = 0.02), particularly versus H2RAs (RR 0.72; p = 0.0008). No significant differences were found in ICU or hospital length of stay as well as for mechanical ventilation duration. Conclusion: In ICU patients, PPI prophylaxis was associated with reduced gastrointestinal bleeding but showed no clear benefit for mortality, ICU or hospital length of stay, or duration of mechanical ventilation. The available evidence does not allow firm conclusions regarding CDI risk because of substantial heterogeneity and very low certainty of evidence. Compared with H2RAs, PPIs provide greater bleeding protection, although possible signals of longer ICU stay and slightly higher mortality require further investigation.
- 16 July 2026
- Published by S. Karger AG in Digestive Diseases
- p. 1-11
Open AccessAssociation between Proton Pump Inhibitor and Clostridioides difficile Risk in ICU Patients: A Systematic Review and Meta-Analysis of Clinical Outcomes
Introduction: Clostridioides difficile infection (CDI) is a leading cause of antibiotic-associated diarrhea in critically ill patients. This meta-analysis evaluated whether proton pump inhibitor-based stress ulcer prophylaxis increases CDI risk and examined associated outcomes, including mortality, gastrointestinal bleeding, and other clinical effects in ICU patients. Methods: The study was prospectively registered on PROSPERO (CRD420251176540). Following PRISMA guidelines, PubMed, Scopus, Cochrane, and Google Scholar were searched (2007 – March 2025) for randomized controlled trials and observational studies comparing PPIs with H2 receptor antagonists (H2RAs) or placebo in ICU patients. Data were pooled using a random-effects model, and heterogeneity was assessed using the I2 statistic. Results: Eight studies (∼58,000 patients) met inclusion criteria. PPI use did not significantly increase CDI risk (OR 1.12; p = 0.49, I2 = 73%) or mortality (RR 1.01; p = 0.70) but significantly reduced gastrointestinal bleeding risk (RR 0.60; p = 0.02), particularly versus H2RAs (RR 0.72; p = 0.0008). No significant differences were found in ICU or hospital length of stay as well as for mechanical ventilation duration. Conclusion: In ICU patients, PPI prophylaxis was associated with reduced gastrointestinal bleeding but showed no clear benefit for mortality, ICU or hospital length of stay, or duration of mechanical ventilation. The available evidence does not allow firm conclusions regarding CDI risk because of substantial heterogeneity and very low certainty of evidence. Compared with H2RAs, PPIs provide greater bleeding protection, although possible signals of longer ICU stay and slightly higher mortality require further investigation.
- 9 July 2026
- Published by BMJ in Emergency Medicine Journal
National patterns in emergency department diagnoses and mortality: insights from the Nationwide Emergency Department Sample
Background: Emergency departments (EDs) are the frontline of acute care in the USA, yet contemporary data on the most common presentations and causes of mortality remain limited. Understanding these patterns is critical for guiding triage, resource allocation and public health priorities. Therefore, using a nationally representative sample of US ED visits from 2016 to 2021, this study aimed to characterise the most common ED diagnoses and leading causes of ED mortality and to assess differences in these patterns across age, sex, race/ethnicity and urban-rural populations. Methods: We conducted a retrospective cohort study of the Nationwide Emergency Department Sample from 2016 to 2021, encompassing more than 680 million weighted ED visits. Outcomes included the five most common presenting diagnoses and causes of ED mortality, stratified by age, sex, race/ethnicity and urban-rural status. Diagnoses were grouped into clinically relevant categories, including acute coronary syndromes (ACS), severe respiratory compromise, trauma and sepsis. Results: During 2016–2021, there were 680 207 479 ED visits and 1 189 848 ED deaths. Chest pain was the leading diagnosis from 2016 to 2019 (4.3–4.4%); in 2021, COVID-19 became the most common presentation (4.8% vs 4.2% for chest pain). Urinary tract infections were more frequent in women (2.6%), whereas sepsis was more common in men (1.6%). Younger adults presented with respiratory infections, abdominal pain and headaches, while older adults had higher rates of sepsis, chronic obstructive pulmonary disease exacerbations and pneumonia. Racial differences were evident: COVID-19 was most frequent in Hispanic patients (3.4%), sepsis in Asian/Pacific Islanders (2.1%) and alcohol intoxication in Native Americans (2.0%). Cardiac arrest was the leading cause of ED death (58–77%). Trauma (7.9%) and self-harm (0.8%) disproportionately affected younger adults, whereas sepsis (up to 2.7%), respiratory compromise (up to 3.7%) and ACS (0.6–1.4%) contributed more to mortality among older adults, women and racial minorities. Conclusion: This national analysis highlights evolving ED utilisation, COVID-19 impact and persistent age-based, sex-based and race-based disparities. Although cardiac arrest dominates ED mortality, the excess burden of sepsis, respiratory failure, ACS, trauma and self-harm in specific populations underscores opportunities to refine triage, target prevention and improve emergency care allocation.
- 9 July 2026
- Published by BMJ in Emergency Medicine Journal
National patterns in emergency department diagnoses and mortality: insights from the Nationwide Emergency Department Sample
Background: Emergency departments (EDs) are the frontline of acute care in the USA, yet contemporary data on the most common presentations and causes of mortality remain limited. Understanding these patterns is critical for guiding triage, resource allocation and public health priorities. Therefore, using a nationally representative sample of US ED visits from 2016 to 2021, this study aimed to characterise the most common ED diagnoses and leading causes of ED mortality and to assess differences in these patterns across age, sex, race/ethnicity and urban-rural populations. Methods: We conducted a retrospective cohort study of the Nationwide Emergency Department Sample from 2016 to 2021, encompassing more than 680 million weighted ED visits. Outcomes included the five most common presenting diagnoses and causes of ED mortality, stratified by age, sex, race/ethnicity and urban-rural status. Diagnoses were grouped into clinically relevant categories, including acute coronary syndromes (ACS), severe respiratory compromise, trauma and sepsis. Results: During 2016–2021, there were 680 207 479 ED visits and 1 189 848 ED deaths. Chest pain was the leading diagnosis from 2016 to 2019 (4.3–4.4%); in 2021, COVID-19 became the most common presentation (4.8% vs 4.2% for chest pain). Urinary tract infections were more frequent in women (2.6%), whereas sepsis was more common in men (1.6%). Younger adults presented with respiratory infections, abdominal pain and headaches, while older adults had higher rates of sepsis, chronic obstructive pulmonary disease exacerbations and pneumonia. Racial differences were evident: COVID-19 was most frequent in Hispanic patients (3.4%), sepsis in Asian/Pacific Islanders (2.1%) and alcohol intoxication in Native Americans (2.0%). Cardiac arrest was the leading cause of ED death (58–77%). Trauma (7.9%) and self-harm (0.8%) disproportionately affected younger adults, whereas sepsis (up to 2.7%), respiratory compromise (up to 3.7%) and ACS (0.6–1.4%) contributed more to mortality among older adults, women and racial minorities. Conclusion: This national analysis highlights evolving ED utilisation, COVID-19 impact and persistent age-based, sex-based and race-based disparities. Although cardiac arrest dominates ED mortality, the excess burden of sepsis, respiratory failure, ACS, trauma and self-harm in specific populations underscores opportunities to refine triage, target prevention and improve emergency care allocation.
- 29 June 2026
- Published by SAGE Publications in Substance use & addiction journal
Substance Use and Motor Vehicle Accident Mortality in the United States: A 22-Year National Analysis
Background: Motor vehicle accidents (MVAs) are a major cause of unintentional injury deaths in the United States. Substance use, particularly alcohol and cannabis, is a well-established contributor to impaired driving and fatal MVAs. This study aimed to analyze mortality trends from MVAs associated with substance use from 1999 to 2020 in the United States. Methods: We conducted a retrospective analysis using the CDC WONDER database, examining death certificates from 1999 to 2020 that recorded both MVAs and substance use in individuals aged ≥15 years. Data were stratified by sex, age group (15-64 and ≥65), race (white and black), and US census region. Age-adjusted mortality rates (AAMRs) were calculated, and temporal trends were analyzed using the Mann-Kendall trend test. Jointpoint regression analysis was used to calculate Average Annual Percentage Change (AAPC). Results: A total 24 152 deaths were recorded, with an overall AAMR of 0.46 per 100 000 population. While overall trends were stable, a significant increase in AAMR was observed among women (AAPC: 3.04% increase; P = .002), particularly white women (+4.3%) and women in the West (+2.0%). Older men (≥65) also experienced a significant rise (τ: 0.63; P < .001). Men consistently had higher mortality than women across all demographics ( P < .001). Regionally, men in the Northeast experienced a significant decline (τ: −0.57). Conclusion: While total substance-related MVA mortality remained stable, the rising mortality among women, older men, and certain subgroups highlights shifting risk profiles. These findings underscore the need for targeted, demographically inclusive public health strategies and equitable resource allocation to reduce preventable deaths.
- 29 June 2026
- Published by SAGE Publications in Substance use & addiction journal
Substance Use and Motor Vehicle Accident Mortality in the United States: A 22-Year National Analysis
Background: Motor vehicle accidents (MVAs) are a major cause of unintentional injury deaths in the United States. Substance use, particularly alcohol and cannabis, is a well-established contributor to impaired driving and fatal MVAs. This study aimed to analyze mortality trends from MVAs associated with substance use from 1999 to 2020 in the United States. Methods: We conducted a retrospective analysis using the CDC WONDER database, examining death certificates from 1999 to 2020 that recorded both MVAs and substance use in individuals aged ≥15 years. Data were stratified by sex, age group (15-64 and ≥65), race (white and black), and US census region. Age-adjusted mortality rates (AAMRs) were calculated, and temporal trends were analyzed using the Mann-Kendall trend test. Jointpoint regression analysis was used to calculate Average Annual Percentage Change (AAPC). Results: A total 24 152 deaths were recorded, with an overall AAMR of 0.46 per 100 000 population. While overall trends were stable, a significant increase in AAMR was observed among women (AAPC: 3.04% increase; P = .002), particularly white women (+4.3%) and women in the West (+2.0%). Older men (≥65) also experienced a significant rise (τ: 0.63; P < .001). Men consistently had higher mortality than women across all demographics ( P < .001). Regionally, men in the Northeast experienced a significant decline (τ: −0.57). Conclusion: While total substance-related MVA mortality remained stable, the rising mortality among women, older men, and certain subgroups highlights shifting risk profiles. These findings underscore the need for targeted, demographically inclusive public health strategies and equitable resource allocation to reduce preventable deaths.
- 16 March 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (3) , 1-6
Temporal trends in the incidence, mortality, and prevalence of gallbladder and biliary diseases in high-income countries compared to the USA, 1990 to 2021
Gallbladder and biliary diseases remain major global health concerns, with trends shaped by lifestyle, metabolic risk factors, and healthcare access. This study evaluated long-term changes in age-standardized incidence (ASIR), prevalence (ASPR), and mortality (ASMR) in high–Social Demographic Index (SDI) countries and the United States from 1990 to 2021. Data were obtained from the Global Burden of Disease 2021 database. ASIR, ASPR, and ASMR were extracted for both regions. Joinpoint regression analysis generated annual percentage changes with 95% confidence intervals to identify significant temporal shifts. In high-SDI countries, males showed declines in ASMR (2.03 to 1.67), ASPR (3210.0 to 2962.4), and ASIR (987.4 to 932.0) per 100,000. Females showed similar reductions: ASMR 1.79 to 1.34, ASPR 5141.8 to 4352.3, and ASIR 1912.0 to 1706.7. In the US, ASMR, ASPR, and ASIR decreased from 1.57 to 1.29, 2495.8 to 2278.2, and 757.5 to 716.0 in males, and from 1.17 to 0.96, 4921.6 to 3796.5, and 1856.5 to 1519.4 in females. Mortality and prevalence declined in both regions, while incidence showed modest reductions. The persistently higher US burden likely reflects obesity, metabolic disease, and healthcare disparities, emphasizing the need for targeted prevention and equitable access to care.
- 16 March 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (3) , 1-6
Temporal trends in the incidence, mortality, and prevalence of gallbladder and biliary diseases in high-income countries compared to the USA, 1990 to 2021
Gallbladder and biliary diseases remain major global health concerns, with trends shaped by lifestyle, metabolic risk factors, and healthcare access. This study evaluated long-term changes in age-standardized incidence (ASIR), prevalence (ASPR), and mortality (ASMR) in high–Social Demographic Index (SDI) countries and the United States from 1990 to 2021. Data were obtained from the Global Burden of Disease 2021 database. ASIR, ASPR, and ASMR were extracted for both regions. Joinpoint regression analysis generated annual percentage changes with 95% confidence intervals to identify significant temporal shifts. In high-SDI countries, males showed declines in ASMR (2.03 to 1.67), ASPR (3210.0 to 2962.4), and ASIR (987.4 to 932.0) per 100,000. Females showed similar reductions: ASMR 1.79 to 1.34, ASPR 5141.8 to 4352.3, and ASIR 1912.0 to 1706.7. In the US, ASMR, ASPR, and ASIR decreased from 1.57 to 1.29, 2495.8 to 2278.2, and 757.5 to 716.0 in males, and from 1.17 to 0.96, 4921.6 to 3796.5, and 1856.5 to 1519.4 in females. Mortality and prevalence declined in both regions, while incidence showed modest reductions. The persistently higher US burden likely reflects obesity, metabolic disease, and healthcare disparities, emphasizing the need for targeted prevention and equitable access to care.
- Open Access
- 20 November 2025
- Published by Elsevier in Arthroplasty Today
- Vol. 36, 101908
Self-Reducible Neglected Recurrent Posterior Hip Dislocation Treated With Cemented Total Hip Arthroplasty
- 20 November 2025
- Published by Elsevier in Arthroplasty Today
- Vol. 36, 101908
Open AccessSelf-Reducible Neglected Recurrent Posterior Hip Dislocation Treated With Cemented Total Hip Arthroplasty
- 16 November 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (1) , 81-91
Comparing Palliative Approaches for GOO in Locally Advanced Pancreatic Cancer: A Systematic Review and Meta‐Analysis
Gastric outlet obstruction (GOO) in locally advanced pancreatic cancer (LAPC) can be managed with endoscopic duodenal stenting (EDS), gastrojejunostomy (GJ), or EUS‐guided gastroenterostomy (EUS‐GE). In our meta‐analysis of LAPC patients, EDS enabled quicker recovery and chemotherapy but had higher re‐intervention rates, while GJ offered greater durability. Our systematic review showed EUS‐GE had high success and low re‐intervention in malignant GOO, though LAPC‐specific data were lacking. Further comparative studies are needed to guide individualized treatment.
- 16 November 2025
- Published by Wiley in Journal of Surgical Oncology
- Vol. 133 (1) , 81-91
Comparing Palliative Approaches for GOO in Locally Advanced Pancreatic Cancer: A Systematic Review and Meta‐Analysis
Gastric outlet obstruction (GOO) in locally advanced pancreatic cancer (LAPC) can be managed with endoscopic duodenal stenting (EDS), gastrojejunostomy (GJ), or EUS‐guided gastroenterostomy (EUS‐GE). In our meta‐analysis of LAPC patients, EDS enabled quicker recovery and chemotherapy but had higher re‐intervention rates, while GJ offered greater durability. Our systematic review showed EUS‐GE had high success and low re‐intervention in malignant GOO, though LAPC‐specific data were lacking. Further comparative studies are needed to guide individualized treatment.
- 3 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-15
Da Vinci Xi versus laparoscopic transabdominal preperitoneal (TAPP) repair of inguinal hernia: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Transabdominal preperitoneal (TAPP) repair is the gold standard for minimally invasive inguinal hernia surgery. With the advent of robotic surgery, robotic-assisted TAPP (r-TAPP) has emerged as an alternative to conventional laparoscopic TAPP (l-TAPP), although comparative evidence remains limited. We conducted a prospectively registered systematic review and meta-analysis (PROSPERO ID: CRD420251154089) of randomized controlled trials comparing r-TAPP and l-TAPP in adults with inguinal hernias. We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and Google Scholar from inception to September 2025 for relevant studies. The primary outcomes were operative duration and postoperative complications within 30 days. The secondary outcomes included seroma, hematoma, urinary retention, and readmission rates. A random-effects meta-analysis was performed using RevMan 5.4. Evidence certainty was assessed using the GRADE methodology. Three randomized controlled trials encompassing 379 patients (196 r-TAPP and 183 l-TAPP) met the inclusion criteria. Overall operative time showed no significant difference (MD 0.59 min, 95% CI -23.67 to 24.85, I²=98%). However, sensitivity analysis removing the heterogeneity-driving study revealed r-TAPP advantage (-15.20 min, 95% CI -18.58 to -11.82, p < 0.00001). No statistically significant differences were observed for any postoperative complication (OR 0.84, 95% CI 0.19–3.79), seroma (OR 1.00, 95% CI 0.13–8.01), hematoma (OR 0.64, 95% CI 0.08–5.30), urinary retention (OR 0.55, 95% CI 0.17–1.76), or readmission (OR 0.51, 95% CI 0.02–12.14). GRADE certainty ranged from low to very low because of imprecision and inconsistency. Across three randomized trials, r-TAPP and l-TAPP showed similar short-term safety with no confirmed difference in operative time. Substantial heterogeneity—likely related to trial design and experience—limits certainty, and publication bias cannot be reliably assessed with so few studies. Larger, multicenter RCTs with standardized protocols and definitions are needed to establish comparative effectiveness.
- 3 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-15
Da Vinci Xi versus laparoscopic transabdominal preperitoneal (TAPP) repair of inguinal hernia: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Transabdominal preperitoneal (TAPP) repair is the gold standard for minimally invasive inguinal hernia surgery. With the advent of robotic surgery, robotic-assisted TAPP (r-TAPP) has emerged as an alternative to conventional laparoscopic TAPP (l-TAPP), although comparative evidence remains limited. We conducted a prospectively registered systematic review and meta-analysis (PROSPERO ID: CRD420251154089) of randomized controlled trials comparing r-TAPP and l-TAPP in adults with inguinal hernias. We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and Google Scholar from inception to September 2025 for relevant studies. The primary outcomes were operative duration and postoperative complications within 30 days. The secondary outcomes included seroma, hematoma, urinary retention, and readmission rates. A random-effects meta-analysis was performed using RevMan 5.4. Evidence certainty was assessed using the GRADE methodology. Three randomized controlled trials encompassing 379 patients (196 r-TAPP and 183 l-TAPP) met the inclusion criteria. Overall operative time showed no significant difference (MD 0.59 min, 95% CI -23.67 to 24.85, I²=98%). However, sensitivity analysis removing the heterogeneity-driving study revealed r-TAPP advantage (-15.20 min, 95% CI -18.58 to -11.82, p < 0.00001). No statistically significant differences were observed for any postoperative complication (OR 0.84, 95% CI 0.19–3.79), seroma (OR 1.00, 95% CI 0.13–8.01), hematoma (OR 0.64, 95% CI 0.08–5.30), urinary retention (OR 0.55, 95% CI 0.17–1.76), or readmission (OR 0.51, 95% CI 0.02–12.14). GRADE certainty ranged from low to very low because of imprecision and inconsistency. Across three randomized trials, r-TAPP and l-TAPP showed similar short-term safety with no confirmed difference in operative time. Substantial heterogeneity—likely related to trial design and experience—limits certainty, and publication bias cannot be reliably assessed with so few studies. Larger, multicenter RCTs with standardized protocols and definitions are needed to establish comparative effectiveness.
- 27 October 2025
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 47 (2) , 384-397
Rural-Urban Disparities in Inpatient Outcomes for Opioid Overdose: A Nationwide Analysis
Objectives: Substantial gaps in clinical outcomes exist in rural and urban hospitals in the United States. Our findings highlight the impact of geographic location on hospital care, guiding targeted interventions to improve opioid-related outcomes in rural and urban areas. Methods: We used the National Inpatient Sample to examine trends in hospitalizations, in-hospital mortality, length of stay, and inflation-adjusted cost of adults admitted for an opioid overdose between 2016 and 2021. Results: Between 2016 and 2021, age-adjusted hospitalizations consistently declined across urban, rural, and overall populations. Urban hospitalization rates decreased from 700 to 500 per 100 000, while rural rates fell from 150 to under 100 per 100 000. Strong negative correlations indicated significant downward trends in hospitalizations across all groups (urban and total: τ = −0.99, P = .008; rural: τ = −0.99, P = .009). Rural patients had higher odds of in-hospital mortality (OR [95% CI]: 1.24 [1.1-1.4], P < .001), requiring invasive mechanical ventilation (OR [95% CI]: 1.46 [1.37-1.56], P < .001), and hemodialysis (OR [95% CI]: 1.64 [1.42-1.89], P < .001), with similar findings in propensity-matched cohorts. Additionally, rural patients were more likely to develop venous thromboembolism (VTE) (OR [95% CI]: 1.20 [1.00-1.43], P = .045), anoxic brain damage (OR [95% CI]: 1.15 [1.02-1.30], P = .025), and acute liver failure (OR [95% CI]: 1.34 [1.18-1.53], P < .001), although VTE did not reach significance in matched cohorts ( P = .120). Rural hospitalizations incurred lower inflation-adjusted costs by $1367.89 ( P < .001) and had a shorter adjusted length of stay by 0.49 days ( P < .001) compared to urban settings. Conclusion: In conclusion, significant disparities in outcomes for opioid overdose patients highlight challenges in rural health care, including higher in-hospital mortality and complications. Continued healthcare policy reforms are warranted to alleviate the disparities in rural-urban cardiovascular outcomes.
- 27 October 2025
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 47 (2) , 384-397
Rural-Urban Disparities in Inpatient Outcomes for Opioid Overdose: A Nationwide Analysis
Objectives: Substantial gaps in clinical outcomes exist in rural and urban hospitals in the United States. Our findings highlight the impact of geographic location on hospital care, guiding targeted interventions to improve opioid-related outcomes in rural and urban areas. Methods: We used the National Inpatient Sample to examine trends in hospitalizations, in-hospital mortality, length of stay, and inflation-adjusted cost of adults admitted for an opioid overdose between 2016 and 2021. Results: Between 2016 and 2021, age-adjusted hospitalizations consistently declined across urban, rural, and overall populations. Urban hospitalization rates decreased from 700 to 500 per 100 000, while rural rates fell from 150 to under 100 per 100 000. Strong negative correlations indicated significant downward trends in hospitalizations across all groups (urban and total: τ = −0.99, P = .008; rural: τ = −0.99, P = .009). Rural patients had higher odds of in-hospital mortality (OR [95% CI]: 1.24 [1.1-1.4], P < .001), requiring invasive mechanical ventilation (OR [95% CI]: 1.46 [1.37-1.56], P < .001), and hemodialysis (OR [95% CI]: 1.64 [1.42-1.89], P < .001), with similar findings in propensity-matched cohorts. Additionally, rural patients were more likely to develop venous thromboembolism (VTE) (OR [95% CI]: 1.20 [1.00-1.43], P = .045), anoxic brain damage (OR [95% CI]: 1.15 [1.02-1.30], P = .025), and acute liver failure (OR [95% CI]: 1.34 [1.18-1.53], P < .001), although VTE did not reach significance in matched cohorts ( P = .120). Rural hospitalizations incurred lower inflation-adjusted costs by $1367.89 ( P < .001) and had a shorter adjusted length of stay by 0.49 days ( P < .001) compared to urban settings. Conclusion: In conclusion, significant disparities in outcomes for opioid overdose patients highlight challenges in rural health care, including higher in-hospital mortality and complications. Continued healthcare policy reforms are warranted to alleviate the disparities in rural-urban cardiovascular outcomes.
- 11 October 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-16
Da Vinci-assisted vs laparoscopic nissen fundoplication for GERD: a systematic review and meta-analysis of randomized controlled trials on patient-reported outcomes, dysphagia, and long-term failure
The comparative effectiveness of da Vinci robot-assisted versus conventional laparoscopic Nissen fundoplication for gastroesophageal reflux disease remains controversial despite increasing adoption of robotic platforms. Previous meta-analyses have yielded conflicting results regarding patient-centered outcomes and long-term durability. We conducted a systematic review and meta-analysis of randomized controlled trials comparing da Vinci-assisted versus conventional laparoscopic Nissen fundoplication. This review was prospectively registered with PROSPERO (CRD420251139110). We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and grey literature sources through August 2025. Primary outcomes included postoperative dysphagia, proton pump inhibitor use, and intraoperative complications. Secondary outcomes encompassed reoperation rates, operative time, length of stay, and conversion to open surgery. Risk ratios and mean differences were calculated using random-effects models. Evidence certainty was assessed using the GRADE methodology. Four randomized controlled trials involving 160 patients (79 robotic, 81 conventional laparoscopic) met the inclusion criteria. No significant differences were observed in early dysphagia (RR 1.05, 95% CI 0.45–2.45), postoperative proton pump inhibitor use (RR 0.97, 95% CI 0.25–3.79), or intraoperative complications (RR 0.43, 95% CI 0.07–2.81). Secondary outcomes showed no differences in reoperation rates (RR 1.65, 95% CI 0.40–6.90), length of hospital stay (MD -0.03 days, 95% CI -0.41 to 0.36), or conversion rates (RR 1.23, 95% CI 0.19–7.99). Operative time demonstrated substantial heterogeneity; sensitivity analysis revealed significantly longer times with robotics when one outlier study was removed (MD 40.28 min, p < 0.00001). Da Vinci robot-assisted and conventional laparoscopic Nissen fundoplication achieve equivalent clinical outcomes with no significant differences in patient-reported outcomes, complications, or long-term effectiveness, while robotic procedures consistently require longer operative times and substantially higher costs without demonstrable clinical benefits. These findings question the routine application of robotic platforms in antireflux surgery until cost-effectiveness and operative efficiency are optimized.
- 11 October 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-16
Da Vinci-assisted vs laparoscopic nissen fundoplication for GERD: a systematic review and meta-analysis of randomized controlled trials on patient-reported outcomes, dysphagia, and long-term failure
The comparative effectiveness of da Vinci robot-assisted versus conventional laparoscopic Nissen fundoplication for gastroesophageal reflux disease remains controversial despite increasing adoption of robotic platforms. Previous meta-analyses have yielded conflicting results regarding patient-centered outcomes and long-term durability. We conducted a systematic review and meta-analysis of randomized controlled trials comparing da Vinci-assisted versus conventional laparoscopic Nissen fundoplication. This review was prospectively registered with PROSPERO (CRD420251139110). We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and grey literature sources through August 2025. Primary outcomes included postoperative dysphagia, proton pump inhibitor use, and intraoperative complications. Secondary outcomes encompassed reoperation rates, operative time, length of stay, and conversion to open surgery. Risk ratios and mean differences were calculated using random-effects models. Evidence certainty was assessed using the GRADE methodology. Four randomized controlled trials involving 160 patients (79 robotic, 81 conventional laparoscopic) met the inclusion criteria. No significant differences were observed in early dysphagia (RR 1.05, 95% CI 0.45–2.45), postoperative proton pump inhibitor use (RR 0.97, 95% CI 0.25–3.79), or intraoperative complications (RR 0.43, 95% CI 0.07–2.81). Secondary outcomes showed no differences in reoperation rates (RR 1.65, 95% CI 0.40–6.90), length of hospital stay (MD -0.03 days, 95% CI -0.41 to 0.36), or conversion rates (RR 1.23, 95% CI 0.19–7.99). Operative time demonstrated substantial heterogeneity; sensitivity analysis revealed significantly longer times with robotics when one outlier study was removed (MD 40.28 min, p < 0.00001). Da Vinci robot-assisted and conventional laparoscopic Nissen fundoplication achieve equivalent clinical outcomes with no significant differences in patient-reported outcomes, complications, or long-term effectiveness, while robotic procedures consistently require longer operative times and substantially higher costs without demonstrable clinical benefits. These findings question the routine application of robotic platforms in antireflux surgery until cost-effectiveness and operative efficiency are optimized.
- Open Access
- 9 October 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103560
Role of antibiotic prophylaxis in liver transplant patients undergoing endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis
- 9 October 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103560
Open AccessRole of antibiotic prophylaxis in liver transplant patients undergoing endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis